Curis Lifesciences Ltd Logo

Curis Lifesciences Ltd IPO

NSELot: 1000

LISTEDSME
Issue Price128
Listing146.1
Current106
Price Band
120 - ₹128
Lot Size
1,000
Issue Size
₹27.52 Cr
GMP
0
Subscription
3.07x

IPO Schedule

1
Open
7 Nov
2
Close
11 Nov
3
Allotment
12 Nov
4
Listing
14 Nov

About Curis Lifesciences Ltd

Curis Lifesciences Ltd is an SME engaged in the marketing and distribution of pharmaceutical products. They operate primarily through third-party manufacturers, focusing on branded generics and specialty products.

Subscription Status

QIB
8.34x
NII
1.19x
Retail
0.87x
CategoryDay 3Day 2Day 1
QIB96.17x8.34x8.34x
NII115.46x4.06x1.19x
Retail44.28x3.80x0.87x
Total74.39x5.15x3.07x

Risk Factors

Reliance on third-party manufacturers exposes the company to supply chain disruptions and quality control issues.
Competition from larger, more established pharmaceutical companies with greater resources.
Dependence on regulatory approvals and changes in government policies related to pharmaceuticals.

Promoters & Management

The key managerial personnel of Curis Lifesciences Limited include Mr. Dharmesh Dasharathbhai Patel (Chairman and Managing Director), Mr. Piyush Gordhanbhai Antala (Whole-time Director), Mr. Jaimik Mansukhlal Patel (Whole-time Director), Mr. Pragnesh Radheshyam Sharma (Chief Financial Officer), and Mr. Nikhil Purohit (Company Secretary and Compliance Officer). The Board of Directors comprises Mr. Dharmesh Dasharathbhai Patel, Mr. Piyush Gordhanbhai Antala, Mr. Jaimik Mansukhlal Patel, Mr. Siddhant Jayantibhai Pawasia, Mr. Chand Rameshbhai Kanabar, Ms. Grishma A Shewale, and Ms. Dhruvi Shyam Kapadia. The Board includes three Independent Directors and two Woman Directors. The management team brings extensive experience in pharmaceutical manufacturing, finance, and compliance. The promoters have a long history in the pharmaceutical industry and are actively involved in the company's strategic direction and day-to-day operations.